Advertisement

Research Article Free access | 10.1172/JCI113583

Abnormality of calmodulin activity in hypertension. Evidence of the presence of an activator.

S L Huang, Y I Wen, D B Kupranycz, S C Pang, G Schlager, P Hamet, and J Tremblay

Clinical Research Institute of Montreal, Quebec, Canada.

Find articles by Huang, S. in: PubMed | Google Scholar

Clinical Research Institute of Montreal, Quebec, Canada.

Find articles by Wen, Y. in: PubMed | Google Scholar

Clinical Research Institute of Montreal, Quebec, Canada.

Find articles by Kupranycz, D. in: PubMed | Google Scholar

Clinical Research Institute of Montreal, Quebec, Canada.

Find articles by Pang, S. in: PubMed | Google Scholar

Clinical Research Institute of Montreal, Quebec, Canada.

Find articles by Schlager, G. in: PubMed | Google Scholar

Clinical Research Institute of Montreal, Quebec, Canada.

Find articles by Hamet, P. in: PubMed | Google Scholar

Clinical Research Institute of Montreal, Quebec, Canada.

Find articles by Tremblay, J. in: PubMed | Google Scholar

Published July 1, 1988 - More info

Published in Volume 82, Issue 1 on July 1, 1988
J Clin Invest. 1988;82(1):276–281. https://doi.org/10.1172/JCI113583.
© 1988 The American Society for Clinical Investigation
Published July 1, 1988 - Version history
View PDF
Abstract

An apparent increase of calmodulin (CaM) activity was previously observed in the heart and kidney but not in the liver of spontaneously-hypertensive rats (SHR) and mice compared with their corresponding normotensive controls. As this change was due to an elevated recovery of CaM in the organs of the hypertensive animals, the present study was designed to evaluate its activity in hypertension. A CaM activator, detected in heart and kidney supernatants from hypertensive animals, was found to be responsible for this enhanced recovery. Similar results were obtained with passaged, cultured aortic smooth muscle cells from SHR, indicating that the anomaly was not a mere consequence of elevated blood pressure but rather a genetic expression of cells of hypertensive origin. The activator was heat stable, nondialyzable, and recovered in the fraction precipitated with 30-50% ammonium sulfate. Preliminary extraction studies suggest that the activator is contained in a glycolipid fraction. The stimulation of phosphodiesterase by this activator was calcium and CaM dependent. The activator appears to affect the affinity of the phosphodiesterase for CaM rather than the maximal stimulation. The activator was also present at a low concentration in the heart and kidney of normotensive animals. These findings indicate that at least some of the calcium abnormalities implicated in the pathogenesis of hypertension could be the result of interactions between CaM, calcium, and this activator.

Browse pages

Click on an image below to see the page. View PDF of the complete article

Version history
  • Version 1 (July 1, 1988): No description
Advertisement
Advertisement